Souhaitez-vous accéder aux communiqués récents ?

Turin, 22 December 2025. From Italy to Brazil, Iveco Group concludes another year of social impact initiatives around the world: in Italy, Fondazione Telethon – whose research on ultrarare genetic...

EXTON, PA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- New research from Spherix Global Insights shows that the Hidradenitis Suppurativa treatment landscape is entering a period of accelerated change as...

The nanobiotechnology market was valued at USD 172.81 billion in 2024 and is projected to reach USD 420.2 billion by 2034, growing at a CAGR of 9.37%.

New data show DecisionDx-UM combined with PRAME provides superior prediction of metastasis and survival in uveal melanoma compared to NGS.

BRISBANE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across...

MediBeacon® TGFRTM System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers begins in early 2026 NEW...

MediBeacon® TGFR™ System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers begins in early 2026 ST....

Press Release Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026 All clinical trial and long-term stability data required for the preparation of the...

Burlingame, CA, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Global Exosome Research Market is estimated to be valued at USD 241.5 Mn in 2025 and is expected to reach USD 751.2 Mn by 2032, exhibiting a...

LONDON and NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic...